KEY FEATURES
| Full Name | Centromere Protein F |
|---|---|
| Synonym | CENP-F; CENF; Hcp-1; Centromere protein F(350/400kD,Mitosin); AH antigen; Kinetochore protein CENPF; Mitosin |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.15-10ng/mL |
| Sensitivity | 0.06ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human CENPF in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human CENPF. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human CENPF and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human CENPF, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human CENPF. You can calculate the concentration of Human CENPF in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human CENPF ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.47 | 0.88 | 4.85 | 0.45 | 0.86 | 5.23 |
| Standard deviation | 0.03 | 0.05 | 0.16 | 0.03 | 0.04 | 0.23 |
| CV(%) | 5.42 | 5.93 | 3.35 | 6.34 | 5.23 | 4.39 |
RECOVERY
The recovery of Human CENPF spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 91-107 | 98 |
| EDTA plasma (n=8) | 85-100 | 91 |
| Cell culture media (n=8) | 94-107 | 101 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human CENPF in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with CENPF ELISA Kits
| CENPE ELISA Kit | publications with CENPF and CENPE |
| BUB1 ELISA Kit | publications with CENPF and BUB1 |
| CCNB1 ELISA Kit | publications with CENPF and CCNB1 |
| CDC20 ELISA Kit | publications with CENPF and CDC20 |
| NUF2 ELISA Kit | publications with CENPF and NUF2 |
| CDCA8 ELISA Kit | publications with CENPF and CDCA8 |
| BUB1B ELISA Kit | publications with CENPF and BUB1B |
| CENPA ELISA Kit | publications with CENPF and CENPA |
Pathways associated with CENPF ELISA Kit
| Cell Cycle Pathway | Cell Cycle Pathway |
| Cell Cycle, Mitotic Pathway | Cell Cycle, Mitotic Pathway |
| FOXM1 Transcription Factor Network Pathway | FOXM1 Transcription Factor Network Pathway |
| G2/M Transition Pathway | G2/M Transition Pathway |
| Gastric Cancer Network 1 Pathway | Gastric Cancer Network 1 Pathway |
| M Phase Pathway | M Phase Pathway |
| Mitotic Anaphase Pathway | Mitotic Anaphase Pathway |
| Mitotic G2-G2/M Phases Pathway | Mitotic G2-G2/M Phases Pathway |
| Mitotic Metaphase And Anaphase Pathway | Mitotic Metaphase And Anaphase Pathway |
| Mitotic Prometaphase Pathway | Mitotic Prometaphase Pathway |
Diseases associated with CENPF ELISA Kit
| Adenocarcinoma | publications with CENPF and Adenocarcinoma |
| Liver Diseases | publications with CENPF and Liver Diseases |
| Liver Neoplasms | publications with CENPF and Liver Neoplasms |
| Neoplasms, Experimental | publications with CENPF and Neoplasms, Experimental |
| Carcinoma, Hepatocellular | publications with CENPF and Carcinoma, Hepatocellular |
| Breast Neoplasms | publications with CENPF and Breast Neoplasms |
| Prostatic Neoplasms | publications with CENPF and Prostatic Neoplasms |
| Pancreatic Neoplasms | publications with CENPF and Pancreatic Neoplasms |
| Liver Cirrhosis | publications with CENPF and Liver Cirrhosis |
| Lung Neoplasms | publications with CENPF and Lung Neoplasms |
Organs/Tissues associated with CENPF ELISA Kit
| Liver | publications with CENPF and Liver |
| Kidney | publications with CENPF and Kidney |
| Blood | publications with CENPF and Blood |
| Prostate | publications with CENPF and Prostate |
| Brain | publications with CENPF and Brain |
| Lymph Node | publications with CENPF and Lymph Node |
| Stomach | publications with CENPF and Stomach |
| Lung | publications with CENPF and Lung |
| Bone | publications with CENPF and Bone |
| Bone Marrow | publications with CENPF and Bone Marrow |